Bone Research is a premier open-access journal published by SpringerNature, dedicated to advancing the understanding of bone biology and its related disciplines. Established in 2013 and based in the United Kingdom, this journal has quickly ascended to the forefront of scientific inquiry, evidenced by its esteemed Q1 rankings in 2023 across multiple categories including Endocrinology, Diabetes and Metabolism, Histology, and Physiology. With a commendable impact reflected in its Scopus ranks—positioned #2 in Histology, #9 in Endocrinology, and #8 in Physiology—Bone Research serves as a vital platform for researchers, healthcare professionals, and students alike to share and access cutting-edge findings. Since adopting an open-access model in 2014, the journal has empowered an expansive audience by facilitating immediate availability of high-quality research. This aligns with its commitment to foster innovation and collaboration within the fields it encompasses. As it converges its efforts from 2013 to 2024, Bone Research remains a critical resource for those looking to deepen their investigation into bone health and diseases, ensuring its place as a leader in promoting scientific excellence.

Journal of Bone Oncology, published by ELSEVIER, is a pivotal open access journal that has been advancing the field of oncology since its inception in 2012. Focused on the intricate relationship between bone-related malignancies and therapeutic advancements, this journal addresses critical issues in bone oncology, including novel treatments, diagnostic methodologies, and translational research. With a commendable impact factor reflecting its scholarly contributions and ranking in the Q2 category of oncology journals (2023), the Journal of Bone Oncology is recognized within the top 67th percentile across Scopus rankings, showcasing its relevance and quality in the medical oncology landscape. Available in open access, the journal promotes widespread dissemination of knowledge, ensuring that researchers, professionals, and students can access groundbreaking research that informs clinical practices and enhances patient outcomes. Located in Germany and targeting a global audience, the journal’s wealth of resources serves as an essential platform for fostering collaboration and innovation in the oncology community.

Journal of Osteoporosis is a leading open-access journal dedicated to the investigation and dissemination of research in the field of osteoporosis and related bone disorders. Published by HINDAWI LTD, the journal has been fostering academic discourse since 2010, ensuring that critical findings are accessible to researchers, clinicians, and policy-makers alike. With an ISSN of 2090-8059 and an E-ISSN of 2042-0064, it serves as a significant platform for advancing knowledge in Endocrinology, Diabetes, and Metabolism, currently holding Q4 and Q3 categorizations in respective quartiles as of 2023. The journal, which publishes annually and is based in the United States, plays a crucial role in documenting the evolving understanding of bone health, contributing to improved clinical practices and patient outcomes. As it converges insights from diverse fields, it is an essential resource for researchers aiming to impact the future of osteoporosis management and treatment.

Cardiovascular Endocrinology & Metabolism is a leading open-access journal dedicated to advancing our understanding of the interconnections between cardiovascular health and endocrine functions. Published by Lippincott Williams & Wilkins, this journal serves as a vital resource for researchers and clinicians alike, providing timely insights into the intricate relationships between metabolic disorders and cardiovascular diseases. With an impressive impact factor and categorized in Q2 for both Cardiology and Cardiovascular Medicine as well as Endocrinology, Diabetes, and Metabolism, it holds a significant position within its respective fields. The journal has been fully open access since its inception in 2012, ensuring that critical research is accessible to a global audience. By fostering innovation and collaboration, Cardiovascular Endocrinology & Metabolism aims to promote better health outcomes and stimulate novel research directions, making it an essential resource for professionals striving to bridge the gaps between these two critical domains.

JOMR-Journal of Oral & Maxillofacial Research is a leading open-access journal dedicated to the dissemination of high-quality research in the field of oral and maxillofacial sciences. Published by UAB Stilus Optimus, this journal has been a vital resource for researchers, clinicians, and educators since its inception in 2010, promoting innovative findings and insights that advance our understanding of oral health and surgical procedures. With an ISSN of 2029-283X, JOMR publishes a diverse range of articles covering clinical studies, case reports, and reviews, establishing itself as an essential platform for sharing knowledge among professionals in dentistry and maxillofacial surgery. The journal's commitment to open access ensures that its cutting-edge research is freely available to a global audience, enhancing collaboration and fostering academic dialogue within the field. As an important contributor to the scholarly community, JOMR plays a crucial role in shaping future research and practice in oral and maxillofacial care.

Revista de Osteoporosis y Metabolismo Mineral, an esteemed journal published by the SOC ESPANOLA INVESTIGACION OSEA & METABOLISMO MINERAL, stands at the forefront of research in the fields of osteoporosis and mineral metabolism. Established in Spain, this Open Access journal has been providing a platform for the dissemination of innovative research and insights since 2009, ensuring accessibility for all stakeholders in the field. Although currently categorized in the Q4 quartile for Endocrinology, Diabetes and Metabolism (2023), it serves a vital role in fostering academic discourse and collaboration among researchers and healthcare professionals. With its ISSN 1889-836X and E-ISSN 2173-2345, the journal aims to contribute significantly to advancing knowledge and understanding in osteoporosis and associated metabolic disorders. The HIndex is currently not reported, highlighting the journal's emerging impact and potential for growth in the scientific community. Spanning a decade, from 2014 to 2024, the journal’s focus is an invaluable asset for students and professionals seeking to stay informed and engaged in this vital area of medicine.

The International Journal of Endocrinology is a premier peer-reviewed journal, published by HINDAWI LTD, focusing on the rapidly evolving fields of endocrinology, diabetes, and metabolism. Since its establishment in 2009, the journal has embraced an Open Access model, ensuring that cutting-edge research is accessible to a global audience without barriers. With an impressive Scopus rank placing it within the top quartiles of related fields, it ranks #103 in Endocrinology, Diabetes and Metabolism, showcasing its significant contribution to the ongoing discourse in these areas. The journal's scope includes original research, reviews, and clinical studies that advance understanding and treatment strategies for endocrine disorders. By bridging the gap between research, clinical practice, and patient care, the International Journal of Endocrinology serves as an essential resource for researchers, practitioners, and students dedicated to the field of endocrinology. Addressed from its headquarters in the United States, this journal not only contributes to academic advancement but also fosters international collaboration in addressing key challenges in endocrinology.

Actualizaciones en Osteología is a peer-reviewed academic journal dedicated to the dissemination of pivotal research in the field of osteoporosis and mineral metabolism. Published by ASOCIACIÓN ARGENTINA DE OSTEOLOGÍA & METABOLISMO MINERAL, this journal serves as a vital resource for professionals, researchers, and students in medicine, particularly within the subdomains of endocrinology, orthopedics, and radiology. With its ISSN 1669-8975 and E-ISSN 1669-8983, the journal has been operational since 2009 and is located in Córdoba, Argentina. Its increasing relevance is underscored by its categorization in the Q4 quartile across multiple medical disciplines, indicating a committed effort to enhance knowledge in these areas. Although it operates without an open-access model, the journal provides critical insights and updates that are making a significant impact in the evolving landscape of osteology and related fields. By participating in the discussions presented, contributors and readers alike can stay abreast of the latest innovations and research findings in bone health.

CALCIFIED TISSUE INTERNATIONAL is a leading peer-reviewed journal published by Springer, dedicated to advancing our understanding of calcified tissues in relation to their physiological roles, pathophysiology, and therapeutic applications. With an impressive impact factor reflective of its importance in the field, this journal performs a crucial role in disseminating high-quality research that spans multiple disciplines, including Endocrinology, Orthopedics, and Sports Medicine. The journal is highly regarded within its respective categories, achieving Q1 rankings in Orthopedics and Sports Medicine, and demonstrating its commitment to excellence in scientific inquiry. While the journal operates under a traditional subscription model, it remains accessible to researchers and practitioners who seek to stay informed on the latest advancements and innovations in the study of calcified tissues. Established in 1973, CALCIFIED TISSUE INTERNATIONAL continues to be a vital resource for researchers, healthcare professionals, and students keen on exploring the intricate relationships between calcification processes and human health.

BONE, published by Elsevier Science Inc, is a leading peer-reviewed journal that has established itself as a pivotal resource in the fields of Endocrinology, Diabetes and Metabolism, Histology, and Physiology. Since its inception in 1985 and continuing to 2025, this journal has consistently provided high-quality research, evidenced by its impressive Q1 category rankings and strong performance in Scopus metrics—ranking #7 in Histology and achieving notable percentiles in related fields. With a commitment to advancing knowledge and understanding in bone biology and associated pathological conditions, BONE serves as an essential platform for researchers and professionals aiming to contribute to the discourse in skeletal health and disease. While it is not an open-access publication, the journal ensures a broad dissemination of pivotal research findings, making it a critical asset for academics and practitioners devoted to fostering advancements in medical sciences.